Stonepine Capital Management »

Aprea Therapeutics shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Aprea Therapeutics (APRE) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Aprea Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aprea Therapeutics held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aprea Therapeutics by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $377k 137k 2.75
2024-06-30 $558k 137k 4.07